icon-folder.gif   Conference Reports for NATAP  
 
  The International Liver Congress™
EASL - European Association for the
Study of the Liver
Paris France
11-15 April 2018
Back grey_arrow_rt.gif
 
 
 
Effects of Inarigivir (SB9200) Therapy on Immune Responses in Patients with Chronic Hepatitis B (CHB)
 
 
  pdf of slide presentation attached so you can read small details of data in slides below
 
Download the PDF here
 
Reported by Jules Levin
EASL 2018 April 11-15 Paris France
 
Renae Walsh1, Rachel Hammond1, Kathy Jackson1, Ros
Edwards1, Chelsea Macfarlane2, Radhakrishnan P. Iyer2,
Man-Fung Yuen3, Henry LY Chan4, Nezam H. Afdhal2,
Stephen Locarnini1
1 Victorian Infectious Diseases Reference Laboratory,
Melbourne, Australia
2 Spring Bank Pharmaceuticals, Hopkinton, MA, United States
3 University of Hong Kong, Hong Kong, Hong Kong
4 Chinese University of Hong Kong, Hong Kong, Hong Kong

0427181

0427182

0427183

0427184

0427185

0427186

0427187

0427188

0427189

04271810

04271811

04271812

04271813

04271814

04271815

04271816

04271817

04271818